Skip to main content
. 2023 Jul 27;62:102123. doi: 10.1016/j.eclinm.2023.102123

Fig. 7.

Fig. 7

TIME changes between lesions of pre-treatment and post-treatment in CR/PR patients (N = 3). (A–B) Pre-to-post-treatment changes of GEP score in CR/PR patients. (C–D) Pre-to-post-treatment changes of T cell markers in CR/PR patients. Each point in the boxplot represents for one sample. Whiskers show the minimum and maximum of all the data. The horizontal line in the box represents the median, and the top and bottom of each box indicate the 25th and 75th percentile. The significance for differences between pre-treatment and post-treatment samples was tested using Wilcoxon’ s signed-rank test. Statistical tests were two sided.